Serum dickkopf-related protein 1 and sclerostin may predict the progression of chronic kidney disease in Japanese patients

被引：10
|
作者：
Hamada-Ode, Kazu [1 ]
Taniguchi, Yoshinori [1 ]
Shimamura, Yoshiko [1 ]
Fujimoto, Shimpei [1 ]
Terada, Yoshio [1 ]
机构：
[1] Kochi Med Sch, Dept Endocrinol Metab & Nephrol, Nankoku, Kochi, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2019年 / 34卷 / 08期
关键词：
D O I：
10.1093/ndt/gfz078
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：1426 / 1427
页数：2
相关论文
共 50 条
  • [21] Is serum sclerostin a marker of atherosclerosis in patients with chronic kidney disease–mineral and bone disorder?
    Andreja Figurek
    Goce Spasovski
    International Urology and Nephrology, 2018, 50 : 1863 - 1870
  • [22] Dickkopf-related protein-1 inhibition attenuates amyloid-beta pathology associated to Alzheimer's disease
    Menet, Romain
    Bourassa, Philippe
    Calon, Frederic
    ElAli, Ayman
    NEUROCHEMISTRY INTERNATIONAL, 2020, 141
  • [23] RELATIONSHIP OF SCLEROSTIN AND DICKKOPF-1 SERUM LEVELS WITH DISEASE ACTIVITY AND INFLAMMATORY MRI LESIONS IN PATIENTS WITH SPONDYLOARTHRITIS
    Shynkaruk, I.
    Iaremenko, O.
    Fedkov, D.
    Iaremenko, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 924 - 925
  • [24] High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery
    Shi, Ruo-Yu
    Yang, Xin-Rong
    Shen, Qiu-Jin
    Yang, Liu-Xiao
    Xu, Yang
    Qiu, Shuang-Jian
    Sun, Yun-Fan
    Zhang, Xin
    Wang, Zheng
    Zhu, Kai
    Qin, Wen-Xin
    Tang, Zhao-You
    Fan, Jia
    Zhou, Jian
    CANCER, 2013, 119 (05) : 993 - 1003
  • [25] Dietary Sources of Protein and Chronic Kidney Disease Progression: The Proof May Be in the Pattern
    Kelly, Jaimon T.
    Carrero, Juan Jesus
    JOURNAL OF RENAL NUTRITION, 2017, 27 (04) : 221 - 224
  • [26] Serum sclerostin as a potential novel biomarker for heart valve calcification in patients with chronic kidney disease
    Ji, Y-Q
    Guan, L-N
    Yu, S-X
    Yin, P-Y
    Shen, X-Q
    Sun, Z-W
    Liu, J.
    Lv, W.
    Yu, G-P
    Ren, C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (24) : 8822 - 8829
  • [27] Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease
    Wang, Yilun
    Dalbeth, Nicola
    Terkeltaub, Robert
    Zhang, Yuqing
    Li, Xiaoxiao
    Zeng, Chao
    Lei, Guanghua
    Wei, Jie
    JAMA INTERNAL MEDICINE, 2025, 185 (01) : 74 - 82
  • [28] Long-term prognostic impact of osteopontin and Dickkopf-related protein 1 in patients with hepatocellular carcinoma after hepatectomy
    Byeon, Hyerim
    Lee, Seung Duk
    Hong, Eun-Kyung
    Lee, Dong Eun
    Kim, Bo Hyun
    Seo, Yunsung
    Joo, Jungnam
    Han, Sung-Sik
    Kim, Seong Hoon
    Park, Sang-Jae
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (06) : 814 - 820
  • [29] Is serum sclerostin a marker of atherosclerosis in patients with chronic kidney disease-mineral and bone disorder?
    Figurek, Andreja
    Spasovski, Goce
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (10) : 1863 - 1870
  • [30] Study of serum sclerostin levels and its role in vascular calcification in patients with chronic kidney disease
    Ahmed R. Elarbagy
    Yassein S. Yassein
    Mahmoud M. Emara
    Ahmed A. Sonbol
    Khaled M. A. Elzorkany
    Amera A. Sharaf El Deen
    The Egyptian Journal of Internal Medicine, 2019, 31 (4) : 813 - 821
12345